Fanconi anemia Disease
About Gene:
Fanconi anemia (FA) is a rare genetic disorder that is inherited in an autosomal recessive manner, with 2% of cases being inherited in an X-linked recessive manner. It is a rare blood disorder involving all 3 cell lines and is the most common form of inherited aplastic anemia, occurring in 1 in 136000 live births. The condition is frequently diagnosed in children 3-14 years of age. Several proteins encoded by FA genes maintain genomic stability by the formation of DNA interstrand cross links (ICLs), which prevent DNA strand separation. People with Fanconi anemia have mutations in FA genes that affect DNA repair, particularly homologous recombination. This results in genomic instability and increased susceptibility to cytotoxic agents and malignancies. Complications of the disease include bone marrow failure, blood cancer and liver cancer.
Number of Patients: 2
Disease Causing Genes:
Sign and Symptoms:
- Learning disability
- Scoliosis
- Microcephaly
- Short stature
- Abnormal heart, lung, digestive tract
- Vitiligo, darkened areas of skin
- Abnormal ears, deafness
- Malformed kidneys
- Low birth weight
- Small testicles
- Problems in bone structure, extra fingers or abnormal thumbs
- Bone marrow failure
Diagnosis:
Cases are diagnosed based on conditions caused by FA such as physical abnormalities, progressive bone marrow failure, cancers such as acute myeloid leukemia, or head, neck and skin tumors. Other diagnostic tests include bone marrow biopsy, Magnetic Resonance Imaging (MRI) and ultrasound. Blood tests include basal metabolic panel (BMP), complete blood count (CBC) and reticulocyte count. Genetic tests include genetic screening and chromosome breakage test. Prenatal tests include amniocentesis and chorionic villi sampling.
Preventions:
Families with a history of relatives having this condition should undergo genetic counselling to assess their risk of passing on the disease to their offspring. People afflicted with the condition should get vaccination to reduce infections and avoid carcinogenic substances.
Treatment:
Bone marrow transplant Prescription of growth factors (erythropoietin, G-CSF, and GM-CSF) can improve blood cell count Hormone therapy Surgery to correct physical abnormalities or organ defects